Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Conditions
Interventions
Placebo
LIN Dose A
+3 more
Locations
62
United States
HealthStar Research, LLC
Hot Springs, Arkansas, United States
Applied Research Center of Arkansas
Little Rock, Arkansas, United States
Advanced Research Center
Anaheim, California, United States
Kindred Medical Institute for Clinical Trials, LLC
Corona, California, United States
WCCT Global, LLC
Costa Mesa, California, United States
Ark Clinical Research
Long Beach, California, United States
Start Date
November 3, 2015
Primary Completion Date
April 20, 2018
Completion Date
May 29, 2018
Last Updated
June 19, 2019
Lead Sponsor
Forest Laboratories
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions